Gene · 7322
UBE2D2: ubiquitin conjugating enzyme E2 D2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. UBE2D2: ubiquitin conjugating enzyme E2 D2. Genes, record 7322. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7322
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P62837 | Ubiquitin-conjugating enzyme E2 D2 | 147 | 62 | Ensembl, GeneID, HGNC |
Source UniProt
Patents37
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 11622 | P62837 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 11622 | P62837 | Espacenet |
| JP 2025024198 A | 2025-02-19 | 16809 | P62837 | Espacenet |
| JP 2025024198 A | 2025-02-19 | 16810 | P62837 | Espacenet |
| US 11884978 B2 | 2024-01-30 | 788 | P62837 | Espacenet |
| JP 2023550743 A | 2023-12-05 | 71 | P62837 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 95128 | P62837 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 95129 | P62837 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 198099 | P62837 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 198100 | P62837 | Espacenet |
1 to 10 of 37
See all 37 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,070
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | UBE2D2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA021765 | Cancer Center Support Grant (CCSG) | 21 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 7 | 2025 |
| P30GM124165 | NE-CAT: A Resource for Advanced Macromolecular Crystallography | 5 | 2025 |
| R01GM065334 | Solution structure and dynamics of polyubiquitin chains | 5 | 2025 |
| ZIABC010977 | Cbl Proteins as Regulators of Tyrosine Kinase Signaling | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30CA054174 | Mays Cancer Center at UT Health SA | 4 | 2025 |
| P30DK043351 | Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital | 4 | 2025 |
| R35GM128855 | Spindle Assembly Checkpoint Silencing | 4 | 2025 |
1 to 10 of 1,070Source NIH's project files
See all 1,070 nih grantsPapers1,418
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural determinants for FAT10 activation and transfer from UBA6 to E2 enzymes. | Nat Commun | 2026 | 42733088 | PubTator, text mining | PubMed |
| Integrative Bioinformatics and Machine Learning Analysis Identifies Novel Molecular Biomarkers in Prostate Adenocarcinoma. | Int J Mol Sci | 2026 | 42589294 | PubTator, text mining | PubMed |
| Chemical Synthesis of Asymmetric Nucleosomes Reveals Intramolecular Activation of UHRF1 E3 Ligase by H3K9me3. | J Am Chem Soc | 2026 | 42485202 | PubTator, text mining | PubMed |
| Analysis and validation of abnormal signaling pathways and immune cell infiltration characteristics in digestive system cancers based on peroxisome-related genes. | Biol Direct | 2026 | 42298691 | PubTator, text mining | PubMed |
| STAT3 isoform dynamics reveal robust splice ratio maintenance across cytokine-activated human immune cells. | Front Immunol | 2026 | 41993160 | PubTator, text mining | PubMed |
| OTUB1 stabilizes PRRSV matrix protein through a non-canonical deubiquitination mechanism to promote viral replication. | J Virol | 2026 | 41914757 | PubTator, text mining | PubMed |
| High-throughput discovery and characterisation of pentafluorobenzene sulfonamide modifiers of Aurora A kinase. | RSC Chem Biol | 2026 | 41847687 | PubTator, text mining | PubMed |
| Alterations in energy production in a Drosophila model for the X-linked dystonia-parkinsonism-related Taf1 deficiency. | Front Aging Neurosci | 2026 | 41777671 | PubTator, text mining | PubMed |
| Non-hydrolyzable acetyllysine analogs to study protein acetylation in vitro and in cells. | Nat Commun | 2026 | 41723125 | PubTator, text mining | PubMed |
| Role and underlying mechanisms of miR‑200 family in breast cancer (Review). | Int J Oncol | 2026 | 41716019 | PubTator, text mining | PubMed |
1 to 10 of 1,418
See all 1,418 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/7322
GET https://conductscience.org/api/genes/v1/7322/patents?page=2